Tuesday, February 15, 2022

< + > The Road To 340B Was Paved With Good Intentions So Why Are Drug Companies Looking For An Off Ramp?

From a $5 billion program in 2014 to a $30 billion program in 2019, 340B saw a 47% compound annual growth rate in five years, significantly outpacing other government pricing programs. Current estimates place it at about $34 billion today.

No comments:

Post a Comment

< + > Proofpoint’s Intelligent Monitoring Catches Both Accidental and Malicious Email Breaches

Proofpoint understands that data breaches can take place through outgoing as well as incoming communications, and through a wide variety of...